General Information of Drug Transporter (DT)
DT ID DTD0119 Transporter Info
Gene Name SLC17A6
Transporter Name Vesicular glutamate transporter 2
Gene ID
57084
UniProt ID
Q9P2U8
Post-Translational Modification of This DT
Overview of SLC17A6 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X-S-nitrosylation X: Amino Acid

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC17A6 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

100

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC17A6 Asparagine 100 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC17A6 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

101

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC17A6 Asparagine 101 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC17A6 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

470

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC17A6 Asparagine 470 has the potential to affect its expression or activity.

Oxidation

  Cystine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC17A6 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

179

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC17A6 Cystine 179 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC17A6 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

198

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC17A6 Cystine 198 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC17A6 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

516

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC17A6 Cystine 516 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC17A6 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

163

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC17A6 Serine 163 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC17A6 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

171

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC17A6 Serine 171 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC17A6 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

162

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC17A6 Threonine 162 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC17A6 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

164

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC17A6 Threonine 164 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC17A6 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

177

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC17A6 Tyrosine 177 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC17A6 [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

281

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC17A6 Tyrosine 281 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC17A6 [6]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

405

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC17A6 Tyrosine 405 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC17A6 [7]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

179

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at SLC17A6 Cystine 179 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: VGLU2_HUMAN)
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells. Biochim Biophys Acta. 2015 Jun;1854(6):609-23.
4 Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma. J Proteome Res. 2014 Nov 7;13(11):4581-93.
5 Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. Cell Oncol (Dordr). 2011 Apr;34(2):141-53.
6 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
7 MDD-SOH: exploiting maximal dependence decomposition to identify S-sulfenylation sites with substrate motifs. Bioinformatics. 2016 Jan 15;32(2):165-72.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.